Ajanta Pharma Limited (BOM:532331)

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 348.49 billion. The enterprise value is 341.40 billion.

Market Cap	348.49B
Enterprise Value	341.40B

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.87%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	41.84M

Valuation Ratios

The trailing PE ratio is 38.81.

PE Ratio	38.81
Forward PE	n/a
PS Ratio	7.69
PB Ratio	9.48
P/TBV Ratio	9.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	38.02
EV / Sales	7.53
EV / EBITDA	27.15
EV / EBIT	30.34
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	n/a
Interest Coverage	69.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	19.47%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	5.61M
Profits Per Employee	1.11M
Employee Count	8,073
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+25.67%
50-Day Moving Average	2,604.73
200-Day Moving Average	2,845.00
Relative Strength Index (RSI)	62.81
Average Volume (20 Days)	2,897

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 45.32 billion and earned 8.98 billion in profits. Earnings per share was 71.57.

Revenue	45.32B
Gross Profit	34.26B
Operating Income	11.25B
Pretax Income	11.98B
Net Income	8.98B
EBITDA	12.45B
EBIT	11.25B
Earnings Per Share (EPS)	71.57

Balance Sheet

The company has 7.42 billion in cash and 327.90 million in debt, giving a net cash position of 7.09 billion.

Cash & Cash Equivalents	7.42B
Total Debt	327.90M
Net Cash	7.09B
Net Cash Per Share	n/a
Equity (Book Value)	36.77B
Book Value Per Share	293.33
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 75.59%, with operating and profit margins of 24.83% and 19.81%.

Gross Margin	75.59%
Operating Margin	24.83%
Pretax Margin	26.43%
Profit Margin	19.81%
EBITDA Margin	27.48%
EBIT Margin	24.83%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 2.01%.

Dividend Per Share	54.00
Dividend Yield	2.01%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	0.87%
Shareholder Yield	2.88%
Earnings Yield	2.58%
FCF Yield	n/a

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a